- Home
- TRML vs TWO Comparison
TRML vs TWO Comparison
Compare TRML & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- TWO
- Stock Information
- Founded
- TRML 2021
- TWO 2009
- Country
- TRML United States
- TWO United States
- Employees
- TRML N/A
- TWO N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- TWO Real Estate Investment Trusts
- Sector
- TRML Health Care
- TWO Real Estate
- Exchange
- TRML Nasdaq
- TWO Nasdaq
- Market Cap
- TRML 1.2B
- TWO 1.1B
- IPO Year
- TRML N/A
- TWO 2009
- Fundamental
- Price
- TRML $47.90
- TWO $9.66
- Analyst Decision
- TRML Hold
- TWO Buy
- Analyst Count
- TRML 12
- TWO 8
- Target Price
- TRML $47.04
- TWO $12.50
- AVG Volume (30 Days)
- TRML 957.5K
- TWO 1.9M
- Earning Date
- TRML 11-06-2025
- TWO 10-27-2025
- Dividend Yield
- TRML N/A
- TWO 16.16%
- EPS Growth
- TRML N/A
- TWO N/A
- EPS
- TRML N/A
- TWO N/A
- Revenue
- TRML N/A
- TWO $257,735,000.00
- Revenue This Year
- TRML N/A
- TWO N/A
- Revenue Next Year
- TRML N/A
- TWO N/A
- P/E Ratio
- TRML N/A
- TWO N/A
- Revenue Growth
- TRML N/A
- TWO N/A
- 52 Week Low
- TRML $11.56
- TWO $9.50
- 52 Week High
- TRML $48.27
- TWO $14.28
- Technical
- Relative Strength Index (RSI)
- TRML 91.37
- TWO 42.15
- Support Level
- TRML $47.83
- TWO $9.60
- Resistance Level
- TRML $47.94
- TWO $10.22
- Average True Range (ATR)
- TRML 0.11
- TWO 0.17
- MACD
- TRML -0.63
- TWO -0.02
- Stochastic Oscillator
- TRML 38.14
- TWO 9.68
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.